Geert Cauwenbergh of RXi on investing in early stage biotech at Stem Cells & RM Congress 2013

Geert Cauwenbergh, President and Chief Executive Officer of RXi Pharmaceuticals, presented at Stem Cells & Regenerative Medicine Congress 2013 on the topic, 'Making the case for investment in early stage biotech companies -- the RXi experience.' Stem Cells & Regenerative Medicine Congress is where biotechs gather to explore the most promising trends in stem cell, cell and gene therapies. For more information, go to www.terrapinn.com/stemcellsusa. Or, check out our blog at blogs.terrapinn.com/total-biopharma for up to date industry information.